This Is Why with Dr. Busti

The amiodarone and digoxin drug interaction is one of the most clinically important cardiovascular drug interactions to understand because it can raise digoxin exposure and increase the risk of digoxin toxicity.In this episode of This Is Why, Dr. Busti explains why amiodarone can increase digoxin concentrations, how P-glycoprotein inhibition changes digoxin handling, and why clinicians should anticipate the need for digoxin dose adjustment and monitoring rather than react after symptoms appear.You’ll learn why this interaction is not just a memorized warning, but a predictable pharmacokinetic and pharmacodynamic issue involving drug transport, renal elimination, cardiac conduction, and patient-specific monitoring.Topics Covered:Why digoxin has a narrow therapeutic windowHow P-glycoprotein affects digoxin absorption and eliminationWhy amiodarone increases digoxin exposureClinical signs of digoxin toxicityWhy nausea, fatigue, confusion, and bradycardia matterHow to think through dose reduction and monitoringWhy renal function and serum concentrations matterAdditive electrophysiologic effects on heart rate and conductionHow understanding the mechanism improves patient careWhen we understand the why, we improve the how.👉 Get more with a free membership at https://www.thisiswhy.health/Access free downloads from our videosAccess deep-dive content from Dr. BustiOrganize content via playlists & collectionsJoin live Q&AReceive member newslettersCoupons & discounts for exam prep resourcesChapter Table of Contents00:00 - Introduction01:49 - Digoxin's Narrow Therapeutic Index02:31 - P-Glycoprotein: The Key Transporter04:53 - How Amiodarone Inhibits P-Glycoprotein06:37 - Clinical Signs of Digoxin Toxicity08:27 - Managing the Interaction09:59 - Pharmacodynamic Effects on Cardiac Conduction11:19 - Key Clinical Takeaways👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!#Amiodarone #Digoxin #DrugInteraction #DigoxinToxicity #PGlycoproteinSpeaker:Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education.Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes.About This Channel:This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC).Disclaimer:This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Likelihood ratios (LR) are one of the most clinically useful tools in diagnostic testing because they help clinicians determine whether a test meaningfully changes the probability of disease. In this episode of This Is Why with Dr. Busti, Dr. Anthony Busti explains how likelihood ratios integrate sensitivity, specificity, prevalence, and post-test probability into real-world clinical decision-making.This Is Why understanding likelihood ratios (LR) matters for every clinician ordering diagnostic tests. Dr. Busti walks through how positive and negative likelihood ratios influence patient workups, when additional testing is warranted, and how clinicians determine whether a diagnostic test is truly useful.Using practical examples including appendicitis evaluation with the speed bump sign, this episode demonstrates how likelihood ratios help guide evidence-based medicine (EBM) and shared clinical decision-making.Topics Covered:- Likelihood ratios (LR) explained- Positive vs negative likelihood ratios- Pre-test and post-test probability- Disease prevalence and diagnostic testing- Diagnostic decision-making principles- Sensitivity and specificity integration- Fagan nomogram basics- Choosing useful diagnostic tests👉 Get more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resources👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!#LikelihoodRatios #DiagnosticTesting #EBM #PostTestProbability #DrBustiSpeaker:Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education.Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes.About This Channel:This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC).Disclaimer:This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Positive and negative predictive values are critical for understanding what diagnostic test results actually mean in clinical practice. In this episode of This Is Why with Dr. Busti, Dr. Busti explains how predictive values help clinicians determine the probability that a patient truly has — or does not have — a disease after diagnostic testing.This Is Why understanding predictive values matters far beyond memorizing formulas. Dr. Busti breaks down how prevalence changes diagnostic interpretation, why false positives and false negatives matter clinically, and how positive and negative predictive values directly impact patient care decisions.Using practical examples including pregnancy testing, appendicitis evaluation, and abdominal pain over speed bumps, this episode demonstrates how clinicians apply predictive values in real-world diagnostic reasoning.Topics Covered:- Positive predictive value explained- Negative predictive value explained- False positives vs false negatives- Disease prevalence and diagnostic testing- Pre-test probability basics- Clinical interpretation of predictive values- Diagnostic reasoning in practice- Sensitivity vs specificity integration- Appendicitis speed bump sign example- Applying predictive values clinicallyThe goal = make medical education easy and clinically relevant.👉 Get more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resources👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!#PositivePredictiveValue #NegativePredictiveValue #DiagnosticTesting #EvidenceBasedMedicine #DrBustiSpeaker:Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education.Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes.About This Channel:This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC).Disclaimer:This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

ROC curves and the AUC (or c-statistic) are some of the most important — and most misunderstood — concepts in diagnostic testing and evidence-based medicine (EBM). In this episode of This Is Why with Dr. Busti, Dr. Busti explains how ROC curves help clinicians determine diagnostic test cutoffs, balance sensitivity and specificity, and improve diagnostic accuracy in real clinical practice.This Is Why understanding ROC curves matters for clinicians interpreting laboratory tests, screening tools, and diagnostic assays. Dr. Busti breaks down area under the curve (AUC), false positives, false negatives, and why changing diagnostic thresholds directly impacts patient care decisions.Using practical examples like diabetes diagnostic cutoffs and D-dimer testing, this episode explains how clinicians choose acceptable tradeoffs between sensitivity and specificity while minimizing diagnostic error.Topics Covered:- Receiver Operating Characteristic (ROC) curves explained- Area under the curve (AUC)- Sensitivity vs specificity tradeoffs- Diagnostic test cutoff values- Diagnostic accuracy principles- Clinical interpretation of ROC curves- Applying ROC curves in practice👉 Get more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resourcex👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.#ROCCurves #DiagnosticTesting #SensitivityAndSpecificity #EvidenceBasedMedicine #DrBustiSpeaker:Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education.Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes.About This Channel:This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC).Disclaimer:This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Sensitivity and specificity are some of the most misunderstood concepts in evidence-based medicine and diagnostic testing. In this episode of This Is Why with Dr. Busti, Dr. Busti breaks down the clinical meaning behind sensitivity, specificity, true positives, false positives, false negatives, and diagnostic accuracy using practical examples clinicians can immediately apply.This Is Why understanding sensitivity and specificity matters far beyond memorization. Dr. Busti explains how clinicians use highly sensitive tests to rule out disease and highly specific tests to rule in disease while also demonstrating how false positives and false negatives influence patient care decisions.You’ll also learn how to interpret 2x2 diagnostic tables, understand diagnostic accuracy, and apply concepts like SNOUT and SPIN correctly in clinical reasoning and evidence-based medicine.Topics Covered:- Sensitivity vs specificity explained- True positives and false negatives- True negatives and false positives- Diagnostic accuracy basics- Rule in vs rule out testing- SNOUT and SPIN concepts- Clinical interpretation of diagnostic tests- 2x2 diagnostic tables explained- False positive and false negative errors- Applying diagnostic testing clinicallyThe goal = make medical education easy and clinically relevant.👉 Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/*** [ ADD GPT SLUG HERE ] ***👉 Get more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resources👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!#SensitivityAndSpecificity #DiagnosticTesting #EvidenceBasedMedicine #DiagnosticAccuracy #DrBustiSpeaker:Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education.Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes.About This Channel:This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC).Disclaimer:This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Diagnostic tests used in research and clinical practice are essential to evidence-based medicine because they shape how clinicians diagnose disease, interpret tests, and make patient care decisions. In this episode of This Is Why with Dr. Busti, Dr. Busti explains how the precision and accuracy of diagnostic studies are designed, validated, and critically appraised using clinically relevant examples and practical reasoning.This Is Why understanding sensitivity, specificity, predictive values, and likelihood ratios matters far beyond memorization. Dr. Busti walks through how clinicians determine whether a diagnostic test is useful, how bias affects study validity, and why gold-standard reference testing is critical in medical research.Topics Covered:- Diagnostic tests in clinical medicine- Precision and accuracy of diagnostic tests explained- Bias and error in diagnostic studies- Considerations about the Gold Standard or Reference TestsThe goal = make medical education easy and clinically relevant.👉 Get more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resources👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!#DiagnosticStudies #Diagnostictests #EvidenceBasedMedicine #EBM #DrBustiSpeaker:Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education.Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes.About This Channel:This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC).Disclaimer:This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Diagnostic studies are foundational to evidence-based medicine because they help clinicians determine disease presence, severity, progression, and treatment response. In this episode of This Is Why with Dr. Busti, Dr. Busti explains the essential framework behind diagnostic studies, including sensitivity, specificity, predictive values, likelihood ratios, and critical appraisal tools used to evaluate study validity.This Is Why understanding diagnostic studies matters for every clinician. Dr. Busti breaks down how diagnostic assays are developed, validated, and interpreted using practical clinical examples, including troponins, HIV viral load monitoring, BNP in heart failure, and lactate clearance in sepsis.You’ll also learn how evidence-based medicine frameworks differ for diagnostic research, including PER, PIRT, and PIRO formats, along with the importance of gold standard reference tests, observer agreement, bias reduction, and diagnostic study reporting standards.Topics Covered:- Diagnostic studies in clinical medicine- Sensitivity vs specificity explained- Positive and negative predictive values- Pre-test and post-test probability- Likelihood ratios and diagnostic accuracy- Gold standard reference testing- Evidence-based medicine diagnostic frameworks- Bias and validity in diagnostic studies- QUADAS-2 critical appraisal overview- Applying diagnostic evidence clinically👉 High-Yield EBM Practice Questions: https://www.highyieldmedreviews.com/ebm-biostatistics-literature-evaluation-online-review-course👉 Get more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resources👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!#DiagnosticStudies #SensitivityAndSpecificity #EvidenceBasedMedicine #ClinicalReasoning #MedicalDiagnostics #DrBustiSpeaker:Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education.Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes.About This Channel:This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC).Disclaimer:This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Regression analysis explained — understanding how variables influence outcomes is essential for interpreting clinical research in this episode of This Is Why with Dr. Busti.Dr. Busti breaks down regression analysis and how it helps identify relationships between variables while controlling for confounders. This Is Why mastering regression allows you to determine whether an intervention truly drives outcomes—or if other factors are influencing the results.You’ll learn the difference between linear and multivariate regression, how independent and dependent variables interact, and why controlling for confounders is critical for internal validity. Dr. Busti also connects regression analysis to the bigger picture of evidence-based medicine, helping you integrate statistical tools into real clinical decision-making.Topics Covered:- What regression analysis actually measures- Independent vs dependent variables- Linear regression and line of best fit- Multivariate (multilinear) regression explained- Logistic regression and outcome prediction- Identifying and controlling confounders- Reasons variables may not show significance- Role of sample size and statistical power- Internal vs external validity connection- Applying regression to clinical research interpretationThe goal = make medical education easy and clinically relevant.👉 Get more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resources👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!#regressionanalysis #confounders #biostatistics #clinicalresearch #Dr BustiSpeaker:Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education.Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes.About This Channel:This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC).Disclaimer:This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Tamsulosin for kidney stones is one of the most commonly prescribed therapies for ureteral stones — but does it actually help? In this episode of This Is Why with Dr. Busti, we break down the landmark SUSPEND trial and explain why the answer depends on the patient, the stone size, and the clinical context.This Is Why many clinicians changed how they approach medical expulsive therapy after SUSPEND. But the real lesson is not simply whether to use tamsulosin — it’s understanding which patients are most likely to benefit and why later evidence refined the conversation.Dr. Busti walks through the trial design, the limitations of pragmatic endpoints, subgroup nuance, and how later studies reshaped guideline recommendations for distal ureteral stones.Topics Covered:- Why the SUSPEND trial changed kidney stone management- Medical expulsive therapy explained- How tamsulosin works in ureteral stones- Why stone size matters clinically- Distal vs proximal ureteral stones- Understanding the ceiling effect in clinical trials- Why most stones ≤5 mm pass spontaneously- Evidence for alpha blockers in larger stones- CT-confirmed stone passage vs intervention outcomes- How later trials refined the evidence- Current EAU, NICE, and AUA guidance- Which patients may benefit from tamsulosin- Why nifedipine fell out of favor- Applying evidence at the bedside- Patient selection in evidence-based medicineThe goal = make medical education easy and clinically relevant.👉 Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/tamsulosin-kidney-stones-suspend-trial👉 Get more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resourcesChapter Table of Contents00:00 - Introduction02:02 - Why the SUSPEND Trial Was Needed04:00 - Study Design & Primary Outcome07:09 - Trial Results09:15 - Interpreting the Findings11:02 - Later Evidence & Meta-Analyses13:34 - Guidelines & Clinical Recommendations15:52 - Bedside Application and Practice Takeaways18:23 - Conclusion👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!#Tamsulosin #KidneyStones #MedicalExpulsiveTherapy #SUSPENDTrial #DrBustiSpeaker:Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education.Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes.About This Channel:This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC).Disclaimer:This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Epistaxis explained by Dr. Busti. In this episode on This Is Why, we break down why epistaxis happens, how clinicians think through causes of bleeding, and why the location of bleeding matters clinically.Dr. Busti explains anterior vs posterior epistaxis, common risk factors, medication-related bleeding, vascular anatomy, and when recurrent nosebleeds may signal a more serious underlying condition.This episode connects anatomy, physiology, pathology, and clinical reasoning so healthcare professionals can better understand the “why” behind epistaxis and nosebleed management.Topics Covered:- What epistaxis means clinically- Why nosebleeds happen- Dryness and nasal mucosal irritation- Trauma and nose picking- Inflammation and upper respiratory infections- Anticoagulants antiplatelets and NSAIDs- Intranasal steroids and cocaine exposure- Bleeding disorders and thrombocytopenia- Hereditary hemorrhagic telangiectasia HHT- Leukemia liver disease and vasculitis- Kiesselbach plexus anatomy- Anterior vs posterior epistaxis- Why posterior bleeds are more concerning- Risk factors for recurrent epistaxis- Initial management principles for nosebleeds- Why anatomy changes treatment decisions👉 Get more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resourcesChapter Table of Contents00:00 - Introduction01:11 - Pop Culture vs Clinical Reality02:55 - Definition of Epistaxis04:17 - Common Causes of Nosebleeds07:42 - Medications & Bleeding Risk09:00 - Systemic Diseases & Structural Causes11:36 - Nasal Blood Supply & Kiesselbach's Plexus13:11 - Anterior vs Posterior Epistaxis15:04 - Treatment & Management of Epistaxis16:21 - Conclusion👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!#Epistaxis #Nosebleed #AnteriorEpistaxis #PosteriorEpistaxis #DrBustiSpeaker:Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education.Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes.About This Channel:This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC).Disclaimer:This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Effect size (Relative risk vs odds ratio vs hazard ratio & NNT and NNH explained — This Is Why understanding these concepts is essential for interpreting clinical trials with Dr. Busti.In this episode of This Is Why, Dr. Busti breaks down relative risk (RR), odds ratios (OR), absolute risk reduction (ARR), absolute risk increase (ARI), number needed to treat (NNT), and number needed to harm (MMH) in a way that connects directly to real clinical decision-making. This Is Why learning the “why” behind these calculations helps you move beyond memorization and actually apply evidence to patient care.You’ll learn how to interpret whether a treatment increases or decreases risk, how to calculate and understand number needed to treat (NNT), and how to avoid common mistakes—like misinterpreting percentages or confusing statistical vs clinical meaning. Dr. Busti also walks through practical examples, including antihypertensive side effects, aspirin for MI prevention, and statin therapy, to show how these metrics influence real-world decisions.Topics Covered:- Definition of relative risk (risk ratio)- When to use relative risk (RR) vs odds ratio (OR) vs hazards ratio (HR)- Prospective vs retrospective study design- Interpreting RR- Confidence intervals and statistical significance- Relative risk increase vs reduction- Absolute risk reduction (ARR) explained- Number needed to treat (NNT) & Number needed to harm (NNH) calculations- Clinical vs statistical interpretation of risk- Applying evidence to cost and patient outcomesThe goal = make medical education easy and clinically relevant.👉 Get more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resources👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!#relativerisk #oddsratio #nnt #ebm #Dr Busti Speaker:Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education.Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes.About This Channel:This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC).Disclaimer:This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

D-dimer explained for DVT evaluation. This Is Why healthcare professionals must understand what an elevated D-dimer actually means before jumping to conclusions. Dr. Busti walks through a common deep vein thrombosis scenario and explains why compression ultrasonography—not automatic anticoagulation—is the correct next step when DVT is suspected.Many learners incorrectly assume that an elevated D-dimer confirms a clot. Others memorize algorithms without understanding the clinical reasoning behind them. In this episode, Dr. Busti breaks down Wells score interpretation, pretest probability, D-dimer limitations, and how clinicians should approach suspected DVT in real-world practice.Whether you're preparing for boards, rotations, residency, or clinical practice, this episode focuses on understanding the "why" behind thrombosis evaluation so you can confidently apply the "how."Topics Covered:- Understanding DVT pretest probability- Interpreting the Wells-DVT score- What D-dimer actually measures- Why elevated D-dimer does not confirm DVT- Negative predictive value and rule-out testing- Age-adjusted versus conventional D-dimer thresholds- When compression ultrasonography is indicated- Why anticoagulation is not always the next step- Common board exam traps in DVT evaluation- Clinical reasoning for suspected venous thromboembolismThe goal = make medical education easy and clinically relevant.👉 Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/d-dimer-explained-suspected-dvt-ultrasound-exam-question👉 Get more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resources👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!#DVT #DDimer #WellsScore #DeepVeinThrombosis #DrBustiSpeaker:Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education.Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes.About This Channel:This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC).Disclaimer:This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Stroke thrombolysis changed emergency neurology forever—but understanding why the NINDS trial mattered is what transforms memorization into clinical decision-making. In this episode of This Is Why with Dr. Busti, we break down the landmark NINDS rt-PA trial that established alteplase as a treatment for acute ischemic stroke and explore the real-world balance between functional recovery and intracerebral hemorrhage risk.Dr. Busti explains how to interpret the trial beyond headlines by walking through the study design, inclusion criteria, outcomes, NNT and NNH calculations, odds ratios, bleeding risk, and the evolution of thrombolytic therapy from alteplase to tenecteplase. This episode also contextualizes modern AHA/ASA recommendations and what clinicians should actually say during bedside risk-benefit discussions with patients and families.This Is Why medical education focuses on understanding the “why” behind clinical decisions so healthcare professionals can apply evidence with confidence and clarity.Topics Covered:- NINDS rt-PA trial explained- Alteplase for acute ischemic stroke- Stroke thrombolysis risks and benefits- Functional recovery vs hemorrhage risk- NNT and NNH interpretation- Odds ratio vs absolute risk- Tenecteplase vs alteplase- Modern stroke thrombolysis guidelines- Shared decision-making in stroke care- Why early reperfusion mattersThe goal = make medical education easy and clinically relevant.👉 Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/ninds-trial-stroke-thrombolysis-risks-benefits🎥 Watch other videos referenced in this episode!P-Value: https://youtu.be/ibl85Flpm94Alpha Value Explained: https://youtu.be/Fmu4HwaGrtUPower Analysis - Type II Error Risk: https://youtu.be/zn9q9E1IOoc👉 Get more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resourcesChapter Table of Contents00:00 - Introduction01:46 - NINDS Trial (1995)04:40 - Trial Design, Inclusion & Exclusion Criteria06:38 - Part 1: The Negative 24-Hour Endpoint Explained11:28 - Part 2: Functional Outcomes That Changed Practice13:45 - NNT, NNH & Explaining Risk to Patients19:18 - One-Year Outcomes & Interpreting Odds Ratios Correctly22:09 - Later Evidence, Meta-Analyses & Expanded Treatment Windows25:30 - Tenecteplase vs Alteplase & Modern Stroke Practice28:17 - Conclusion👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!#AcuteIschemicStroke #NINDSTrial #StrokeThrombolysis #Alteplase #Tenecteplase #DrBustiSpeaker:Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education.Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes.About This Channel:This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC).Disclaimer:This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Confidence intervals are one of the most misunderstood concepts in evidence-based medicine. In this episode of This Is Why with Dr. Busti, we break down what 95% confidence intervals actually mean, how they relate to p values and effect size, and why they are essential for interpreting clinical research correctly.Dr. Busti walks through practical examples involving odds ratios, hazard ratios, relative risk, forest plots, and statistical significance so healthcare professionals can confidently evaluate published literature and apply evidence appropriately in clinical decision-making.Whether you're preparing for boards, learning research interpretation, or improving your evidence-based medicine skills, this episode helps transform statistical confusion into clinical understanding.Topics Covered:- What a 95% confidence interval actually means- Why confidence intervals matter in inferential statistics- Relationship between confidence intervals and p values- Understanding statistical significance- Why confidence intervals can be wide or narrow- Sample size and precision of results- Interpreting odds ratios and hazard ratios- Why crossing 1.0 matters for ratios- Why crossing 0 matters for means- Forest plot interpretation basics- Clinical relevance versus statistical significance- Confidence intervals in meta-analyses- Understanding random error and confounding- Examples from cardiovascular literature- Evidence-based medicine interpretation strategiesThis Is Why with Dr. Busti helps healthcare professionals move beyond memorization by understanding the why behind clinical evidence and patient care decisions.👉 Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/confidence-intervals-explained-medical-statistics👉 Get more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resourcesChapter Table of Contents00:00 - Introduction01:52 - Concept Overview03:29 - What a 95% Confidence Interval Really Means04:39 - Why Narrow CI Matter07:10 - Statistical Significance of CI08:57 - Sample Question12:01 - Integration & Application12:56 - PROactive Trial & Aspirin Meta-Analysis22:07 - Impact of Controlling for Confounders24:01 - Conclusion👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!#evidencebasedmedicine #confidenceinterval #statistics #clinicalresearch #medicaleducation #DrBustiSpeaker:Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education.Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes.About This Channel:This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC).Disclaimer:This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Tinnitus explained clearly—This Is Why it matters clinically with Dr. Busti. Understanding tinnitus as a symptom, not a diagnosis, changes how you think, communicate, and manage patients.In this episode, Dr. Busti breaks down the meaning of tinnitus, its clinical implications, and how proper terminology drives better clinical reasoning. From pathophysiology to medication causes and key descriptors like pulsatile and unilateral tinnitus, this is a foundational concept every healthcare professional must master.This Is Why terminology is more than vocabulary—it’s a tool for thinking.Topics Covered:- What tinnitus actually means clinically- Why tinnitus is a symptom, not a diagnosis- Common patient descriptions of tinnitus- Pathophysiology and brain compensation- Pulsatile vs non-pulsatile tinnitus- Unilateral vs bilateral tinnitus significance- Medication-induced tinnitus causes- Aminoglycosides, loop diuretics, salicylates- Correct pronunciation and why it matters- Clinical reasoning approach to tinnitus- Real-world coping strategies (sound masking)- Cultural references and patient perspectiveThe goal = make medical education easy and clinically relevant.👉 Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/tinnitus-explained-symptom-vs-diagnosis-medical-terminology👉 Get more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resources👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.#tinnitus #tinnitusmeaning #clinicalreasoning #hearingloss #Dr BustiSpeaker:Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education.Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes.About This Channel:This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC).Disclaimer:This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

P values explained clearly in clinical research — This Is Why understanding what a P value means (and does NOT mean) with Dr. Busti is critical for interpreting evidence and applying it to patient care.In this episode, Dr. Busti breaks down one of the most misunderstood concepts in biostatistics: the P value. You’ll learn exactly what a P value tells you about chance, random error, and statistical significance—and more importantly, what it does NOT tell you about clinical relevance.Using landmark clinical trials, including real-world examples, this episode connects statistical interpretation to actual patient care decisions so you can move beyond memorization and truly understand the “why” behind the data.Topics Covered:- What a P value actually represents- What a P value does NOT mean- Why P values do not determine clinical significance- Interpreting P values as probabilities of chance- Relationship between P values and null hypothesis- Type I error and limitations of P values- Role of bias, power, and random error- UKPDS trial interpretation and sample size impact- HOPE trial interpretation and clinical relevance- Statistical vs clinical significance in practice- Internal vs external validity👉 Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/p-value-interpretation-clinical-significance-board-question👉 Get more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resources👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!#pvalue #statisticalsignificance #clinicalresearch #evidencebasedmedicine #DrBustiSpeaker:Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education.Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes.About This Channel:This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC).Disclaimer:This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Why sulfonylureas cause hypoglycemia becomes much easier to understand once you know how pancreatic beta cells regulate insulin secretion. In this episode of This Is Why with Dr. Busti, we walk through a board-style pharmacology question that connects ATP-sensitive potassium channels, membrane depolarization, calcium influx, and insulin release into one clinically useful framework.Instead of memorizing isolated diabetes medication facts, this episode explains the physiology behind insulin secretagogues and why missed meals can become dangerous in patients taking sulfonylureas or meglitinides. Dr. Busti breaks down the mechanism step-by-step so you can reason through pharmacology questions, recognize common board-style distractors, and apply the concepts clinically.This Is Why stronger pharmacology understanding improves both exam performance and patient care.Topics Covered:- Hypoglycemia caused by sulfonylureas- Meglitinide mechanism of action- ATP-sensitive potassium channels- Pancreatic beta-cell physiology- Insulin secretion pathway- Membrane depolarization in beta cells- Calcium influx and insulin release- Board-style pharmacology reasoning- High-yield endocrinology pharmacology- Missed meal hypoglycemia risk- Toxicology and recurrent hypoglycemia- Octreotide in sulfonylurea toxicity- Clinical reasoning for diabetes medications- Mechanism-based test-taking strategies👉 Get more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resources👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.#Sulfonylureas #Hypoglycemia #InsulinSecretion #BetaCellPhysiology #DrBustSpeaker:Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education.Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes.About This Channel:This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC).Disclaimer:This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

In this episode on This Is Why, Dr. Busti breaks down one of the most commonly misunderstood biostatistics concepts: correlation vs coefficient of determination. You’ll learn how to interpret the correlation coefficient (r), what it actually tells you about relationships between variables, and why it does NOT imply causation.Then we connect that foundation to R² (coefficient of determination) — and This Is Why it’s critical for understanding how much variability one variable explains in another. Through clinical context and practical examples, you’ll see how these concepts apply to real-world decision-making, not just test questions.If you’ve ever confused association with causation or struggled to interpret R values, this episode will help you connect the “why” behind the numbers.Topics Covered:- Correlation coefficient (r) definition- Strength vs direction of relationships- Why correlation does NOT equal causation- Confounding variables explained- Interpreting R values clinically- Coefficient of determination (R²)- Variability explained between variables- Clinical example: calories and weight- Relationship vs prediction in statisticsThe goal = make medical education easy and clinically relevant.👉 Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/correlation-coefficient-vs-r-squared👉 Get more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resources👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!#correlation coefficient #R squared #biostatistics explained #coefficient of determination #Dr BustiSpeaker: Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education. Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes. About This Channel: This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC). Disclaimer: This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

ACE inhibitors after myocardial infarction — Dr. Busti explains the GISSI-3 trial and what it actually changed in clinical practice on this episode of This Is Why.After the initial management of acute MI, the real question becomes: what else improves survival and prevents long-term damage? The GISSI-3 trial tackled this directly, evaluating early ACE inhibitor therapy and routine nitrate use in a large, real-world population.Dr. Busti breaks down how lisinopril provided a modest but meaningful mortality benefit—and why that matters more than it seems. More importantly, we explore the why behind early RAAS blockade, how it impacts ventricular remodeling, and which patients benefit the most.This is not about memorizing treatment steps—it’s about understanding how small, evidence-based decisions compound to improve patient outcomes.Topics Covered:- Why the GISSI-3 trial was needed- Trial design and 2x2 factorial structure- Early ACE inhibitor therapy after MI- Mortality and combined endpoint outcomes- Absolute vs relative risk reduction- Why nitrates did not improve survival- Mechanism of RAAS blockade and remodeling- High-risk subgroups (diabetes, anterior MI, LV dysfunction)- Limitations of GISSI-3 in modern practice- Applying early ACE inhibitors clinically👉 Download the full clinical trial handout with a free membership at: https://www.thisiswhy.health/topics/gissi-3-trial-ace-inhibitors-after-mi-landmark-clinical👉 Get more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resources#GISSI3Trial #ACEinhibitorsMI #postMIcare #ventricularremodeling #Dr Bust👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!#GISSI3Trial #ACEinhibitorsMI #postMIcare #ventricularremodeling #DrBustSpeaker: Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education. Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes. About This Channel: This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC). Disclaimer: This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content. 

Mean, median, mode, standard deviation, and standard error explained in the context of clinical research and data interpretation.In this This Is Why lecture, Dr. Busti walks through the core measures of central tendency and variability and shows how they relate to data type, study design, and proper interpretation.This is where many learners make mistakes—especially when interpreting skewed data, choosing between mean vs median, or understanding the difference between standard deviation and standard error.This episode builds directly on the Biostatistics Framework and helps you recognize when data may be misleading or incorrectly presented.Topics Covered:- Mean, median, and mode explained- Measures of variability and dispersion- Standard deviation vs standard error of the mean- How data type determines statistical description- Nominal, ordinal, and continuous data (applied concepts)- Skewed data (positive vs negative skew)- Relationship between mean, median, and mode- Interquartile range (IQR) explained- Identifying outliers in clinical data- 95% confidence interval (conceptual understanding)The goal = make medical education easy and clinically relevant.👉 Looking for Q-Banks to practice applying the concepts? We have Q-Banks at: https://www.highyieldmedreviews.com/ebm-biostatistics-literature-review-medicine📚 Need a structured curriculum for your university or residency program? We would love to discuss how we can partner with you: https://www.highyieldmedreviews.com/residency-training-programs-services-and-package👉 Get more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resources👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!#meanmedianmode #standarddeviation #standarderror #biostatisticsbasics #DrBustiSpeaker: Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education. Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes. About This Channel: This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC). Disclaimer: This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Amiodarone in cardiac arrest — Dr. Busti breaks down the ARREST trial and what it actually means for patient outcomes in this episode of This Is Why.When ventricular fibrillation persists after multiple shocks, what’s the next step? The ARREST trial gave us one of the first randomized answers—but understanding the why behind the results is what truly changes how you practice.Dr. Busti walks through the evidence behind amiodarone in shock-refractory VF/pulseless VT, highlighting what improved—and what didn’t. You’ll learn how to interpret short-term survival benefits, weigh adverse effects, and apply this data within modern ACLS algorithms.This is not just about memorizing steps—it’s about understanding the clinical impact so you can make better decisions under pressure.Topics Covered:- Why the ARREST trial was needed- Trial design and patient population- Survival to hospital admission vs meaningful outcomes- Amiodarone benefits and limitations- Adverse effects in cardiac arrest- ACLS guideline integration- Amiodarone vs lidocaine perspective- Clinical decision-making in refractory VF- Limitations of the ARREST trial- What actually improves survival in cardiac arrest👉 Download the full clinical trial handout and framework at: https://www.thisiswhy.health/topics/amiodarone-cardiac-arrest-trial-landmark-clinical👉 Get more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resources👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.#amiodarone cardiac arrest #ARREST trial #ventricular fibrillation #ACLS algorithm #Dr BustiSpeaker:Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education.Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes.About This Channel:This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC).Disclaimer:This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

What does “sternutate” actually mean, and why does medicine use complex terms for simple human experiences like sneezing? In this episode of This Is Why, Dr. Busti breaks down the medical term sternutate, its Latin origin, and how it connects to the physiology of sneezing as a protective reflex. This episode goes beyond memorization to focus on clinical reasoning—helping healthcare professionals understand how a common symptom like sneezing can point to underlying conditions such as allergic rhinitis, infections, or environmental triggers. If you want to better understand the “why” behind medical terminology and apply it to real patient care, this episode will help you think more clearly and clinically.👉 Get more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resources👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.🔔 We'd love if you'd leave us a review on Apple Podcast or Spotify! It helps other clinicians like you find us. #sternutate #medicalterminology #sneezing #clinicalreasoning #drbustiSpeaker:Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education.Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes.About This Channel:This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC).Disclaimer:This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Power analysis is essential for interpreting clinical research and determining whether a study can truly detect a meaningful difference.In this lecture on This Is Why, Dr. Busti will explain what statistical power really means, how it relates to beta and Type II error, and why sample size plays a critical role in identifying true differences in clinical studies. He walks through the conceptual meaning of power—not just the formula—and shows how clinicians and researchers should interpret study results when no difference is found.This lecture is part of the This Is Why (TIW) evidence-based medicine series, a connected playlist designed to build a deeper understanding of biostatistics and clinical reasoning. Be sure to explore the full series to strengthen your ability to critically evaluate medical literature.Topics Covered:- Definition of statistical power (1 − beta)- Type II error and its clinical meaning- Relationship between power and beta- Why power reflects the probability of detecting a true difference- Impact of sample size on study conclusions- Factors influencing power analysis- One-sided vs two-sided hypothesis testing- Study design considerations (crossover vs randomized trials)- Interpreting studies with no statistically significant difference- Clinical implications of underpowered studiesThe goal = make medical education easy and clinically relevant.👉 Get more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resources👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!#PowerAnalysis #TypeIIError #Biostatistics #EvidenceBasedMedicine #Dr BustiSpeaker: Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education. Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes. About This Channel: This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC). Disclaimer: This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Alpha value and Type I error are foundational concepts in biostatistics and clinical research interpretation.In this lecture on This Is Why, Dr. Busti will explain what alpha represents, how it is determined, and how clinicians should interpret it when evaluating medical literature. This session clarifies the relationship between alpha, Type I error, hypothesis testing, and study power, helping learners connect statistical theory to real clinical decision-making.This lecture is part of the broader This Is Why evidence-based medicine series, where each concept builds on previous topics to strengthen your ability to critically evaluate research.Be sure to explore the full playlist to connect concepts like hypothesis testing, power analysis, and statistical errors.Topics Covered:- Definition of alpha in clinical research- Alpha as probability of Type I error- Interpreting alpha in published studies- One-tailed vs two-tailed hypothesis testing- Relationship between alpha and study power- Type I error vs correct decision-making- Clinical implications of statistical error- Role of alpha in evidence-based medicineThe goal = make medical education easy and clinically relevant.👉 Get more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resources👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!#alpha value #type I error #biostatistics #clinical research #Dr BustiSpeaker: Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education. Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes. About This Channel: This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC). Disclaimer: This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Parametric vs Non-Parametric statistical tests are explained, and how they relate to data type, distribution, and study design.In this lecture on This Is Why, Dr. Busti brings the full biostatistics framework of the Statistical Analysis Plan (SAP) together—connecting data type, distribution, and study groups to the correct statistical analysis.Understanding when to use parametric vs. nonparametric tests is critical for interpreting clinical research and avoiding common mistakes when evaluating data in evidence-based medicine (EBM).This lecture reinforces how normal vs skewed data, outliers, and data classification influence statistical decision-making.Topics Covered:- Parametric vs nonparametric statistical tests- Normal distribution vs non-normal data- Role of data type in statistical analysis- Impact of outliers and skewed data- Nominal, ordinal, and continuous data review- How distribution affects test selection- Connecting data, groups, and statistical tests- Interpreting how data is presented in research- Clinical implications of incorrect statistical analysisThe goal = make medical education easy and clinically relevant.👉 Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/parametric-vs-nonparametric-statistical-tests-biostatistics👉 Get more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resources👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!#parametricvsnonparametric #biostatistics #statisticaltests #EBM #DrBustiSpeaker: Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education. Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes. About This Channel: This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC). Disclaimer: This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Independent vs paired study groups explained and how they determine the correct statistical test in clinical research.In this This Is Why lecture, Dr. Busti breaks down one of the most important steps in biostatistics—identifying the type of study groups and how that directly impacts statistical test selection.Understanding whether groups are independent or related is essential for interpreting clinical trials and avoiding common mistakes when reading research.This lecture builds on prior topics and moves you closer to confidently choosing the correct statistical analysis.Topics Covered:- Independent vs paired (related) study groups- How study design determines statistical testing- Randomized controlled trials and independent groups- Crossover and pre-post study designs- Matched and paired data concepts- Number of groups and its impact on analysis- Role of study groups in statistical decision-making- Connecting study design to hypothesis testing frameworkThe goal = make medical education easy and clinically relevant.👉 Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/independent-vs-paired-study-groups-biostatistics👉 Get more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resources👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!#independentvspaired #studygroups #biostatistics #clinicalresearch #Dr BustiSpeaker: Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education. Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes. About This Channel: This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC). Disclaimer: This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Parkinson disease medication discontinuation safety is the focus of this episode of This Is Why with Dr. Busti. In this board-style practice question, we work through a clinical scenario involving adverse effects, medication management, and the reasoning process needed to approach discontinuation decisions safely in practice and on exams.In this episode, Dr. Busti breaks down how to think through a medication safety question step by step, identify common board traps, and connect the pharmacology to real patient care.Topics Covered:- Parkinson disease medication management- Medication discontinuation safety- Adverse effects and treatment adjustment- Board-style pharmacology reasoning- How to analyze discontinuation questions- Common distractors in medication safety questions- Clinical thinking for neurologic drug therapy- Patient counseling during medication changesThe goal = make medical education easy and clinically relevant.👉 Get more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resources👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!#ParkinsonDisease #MedicationSafety #Pharmacology #ClinicalReasoning #DrBustiSpeaker: Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education. Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes. About This Channel: This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC). Disclaimer: This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Types of data for a study's endpoint are explained—nominal, ordinal, or continuous—and how each determines the appropriate statistical test in clinical research.In this lecture on This Is Why, Dr. Busti walks through one of the most critical steps in biostatistics: correctly identifying the type of data based on the study question.This is where many learners make mistakes—especially when distinguishing between ordinal vs continuous data, recognizing skewed data, or understanding when to use parametric vs non-parametric analysis.This lecture connects directly to prior topics on study groups and variability, bringing you closer to confidently choosing the correct statistical test.Topics Covered:- Nominal, ordinal, and continuous data explained- How the study question determines data type- Parametric vs non-parametric data concepts- Normal distribution vs skewed data- Relationship between mean, median, and mode- When continuous data should not be treated as parametric- Impact of outliers on data interpretation- Interpreting data for correct statistical test selection- How endpoints can change data classification (e.g., yes/no vs average)The goal = make medical education easy and clinically relevant.👉 Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/types-of-data-nominal-ordinal-continuous-biostatistics👉 Get more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resources👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!#typesofdata #nominalordinalcontinuous #biostatistics #clinicalresearch #Dr BustiSpeaker: Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education. Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes. About This Channel: This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC). Disclaimer: This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

How do you choose the right statistical test in clinical research?In this This Is Why (TIW) lecture, Dr. Busti introduces the biostatistics decision-making framework that connects hypothesis, study design, and data type to the correct statistical analysis.This is not a memorization lecture—it’s about understanding the structure behind statistical choices so you can evaluate research correctly as a clinician or researcher.This episode sets the foundation for the entire Biostatistics Framework series, where each concept builds step-by-step into practical application.If you’ve ever wondered why a specific statistical test was used in a paper—or whether it was the right one—this is where you start.Topics Covered:- Introduction to biostatistics in clinical research- How to choose the correct statistical test- Role of hypothesis in guiding analysis- Study design and its impact on statistical decisions- Understanding data types in research- Independent vs related groups- Internal validity and bias in clinical studies- Sample vs population inference- Null vs alternative hypothesis (conceptual review)- Overview of the statistical decision frameworkThe goal = make medical education easy and clinically relevant.👉 Get more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resources👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!#biostatistics #clinicalresearch #evidencebasedmedicine #epidemiology #DrBustiSpeaker: Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education. Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes. About This Channel: This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC). Disclaimer: This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

What is dyspnea, and why does it matter in clinical practice? In this episode of This Is Why, Dr. Busti breaks down the medical term dyspnea—commonly described as shortness of breath—and explain how healthcare professionals should think about it beyond simple definitions.Dyspnea should not be solely considered a diagnosis. It is a symptom that requires clinical reasoning. So the question becomes: what is driving the patient’s breathing discomfort? In this episode, Dr. Busti walks through the origin of the term, how it has been used historically, and how modern clinicians evaluate dyspnea across pulmonary, cardiac, and systemic causes.We also connect the concept to real-world scenarios, including examples from Top Gun and The Hunger Games, to help illustrate how breathlessness presents in both physiologic and pathologic contexts.If you’re a healthcare professional, student, or anyone looking to strengthen clinical thinking, this episode will help you understand not just what dyspnea means—but why it matters for patient care.Subscribe to This Is Why with Dr. Busti for more content focused on understanding the “why” behind medical terminology and clinical decision-making.👉 Get more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resourcesChapter Table of Contents*** ADD TIMESTAMP & CHAPTER TITLES HERE ****👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!#dyspnea #shortnessofbreath #clinicalreasoning #medicalterminology #drbustiDisclaimer:This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Internal and external validity are foundational to interpreting clinical research and applying evidence in practice. In this This Is Why lecture, Dr. Busti explains how validity is established, what threatens it, and how clinicians should evaluate it during critical appraisal.This lecture is part of the This Is Why (TIW) evidence-based medicine series, helping clinicians connect study design to real-world decision-making.Topics Covered:- Internal validity vs external validity explained- Independent vs dependent variables- Causality in clinical research- Threats to internal validity (history, maturation, testing, instrumentation)- Statistical regression, selection, and mortality bias- Threats to external validity (testing, selection, setting)- Hawthorne effect and reactive behavior- Multiple-treatment interference- Applying evidence to patient care👉 Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/internal-and-external-validity-research-design-methodology👉 Get more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resources👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!#internalvalidity #externalvalidity #biostatistics #studydesign #DrBustiDisclaimer:This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Types of bias in research and their impact on results are critical to understanding study design, internal validity, and clinical decision-making. In this lecture on This Is Why, Dr. Busti walks through how bias is introduced, how it affects results, and how clinicians should interpret it.This lecture is part of the This Is Why evidence-based medicine (EBM) series, designed to help clinicians connect research methodology to real-world practice.Topics Covered:- Equation of error: truth, bias, and random error- Internal validity and critical appraisal- Selection bias and sampling bias- Confounding and lead-time bias- Recall bias and observer bias- Loss to follow-up and procedure bias- Differential vs non-differential misclassification- Study design hierarchy and risk of bias- Publication bias and clinical trial registries- Why bias control changes effect size👉 Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/types-bias-clinical-research-design-methodology👉 Get more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resources👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!#bias in research #study design #internal validity #evidence based medicine #Dr BustiDisclaimer:This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Picking the right benzodiazepine based on its metabolism is a critical concept for understanding medication safety, especially when considering hepatic function and drug accumulation. In this episode of This Is Why, Dr. Busti walks through a board-style practice question to break down how different metabolic pathways impact clinical decision-making.This case highlights how pharmacokinetics directly influences patient outcomes and why recognizing metabolism patterns is essential for safe prescribing.Topics Covered:- Benzodiazepine metabolism overview- Phase 1 vs Phase 2 hepatic drug metabolism- CYP450 oxidation and active metabolites- Glucuronidation and drug clearance- Pharmacokinetics in older adults- Drug accumulation and prolonged effects- Clinical decision-making in anxiolytic therapy- High-yield pharmacology concepts for board preparationThe goal = make medical education easy and clinically relevant.👉 Get more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resources👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!#benzodiazepinemetabolism #LOTdrugs #practicequestion #cyp450pharmacology #DrBustiDisclaimer:This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

The ultimate guide to types of study designs used in clinical research is explained and made easy for clinicians and researchers. In this lecture on This Is Why, Dr. Busti walks through the major study designs used in medical research and explains how each design affects bias, causality, and the interpretation of clinical evidence. Dr. Busti also addresses the pros and cons of major study designs and when to use a particular study design to answer a particular clinical question. Understanding study design is essential for interpreting medical literature and assessing the internal and external validity of results, thereby informing the application of the information in clinical practice. Different designs—such as randomized controlled trials, cohort studies, case-control studies, and cross-sectional analyses—each have specific strengths, limitations, and risks of bias that influence how results should be applied in clinical practice.This lecture explains how study design fits into the broader clinical research process described by the NIH and how clinicians should evaluate studies when reading the medical literature.As part of the This Is Why (TIW) evidence-based medicine (EBM) series, this lecture focuses on the reasoning behind clinical evidence so clinicians can understand why certain study designs carry more evidentiary weight than others.Topics Covered:- Study design in clinical research- Descriptive vs analytic studies- Observational vs experimental research- Case-control studies- Cohort studies- Cross-sectional studies- Randomized controlled trials (RCTs)- Randomized crossover trials- Explanatory vs pragmatic clinical trials- Qualitative vs quantitative research- Study design hierarchy and risk of bias- Internal vs external validity- Confounders and bias in clinical trials- Clinical trial registration- CONSORT reporting guidelinesThis lecture is part of the This Is Why (TIW) evidence-based medicine (EBM) learning series with Dr. Busti. The series teaches clinicians how clinical studies are designed, how statistical results should be interpreted, and how research findings translate into real patient care decisions.👉 Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/types-of-study-designs-clinical-research-methodology-explained-ultimate-guide👉 Get more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resources👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!#StudyDesign #ClinicalResearch #EvidenceBasedMedicine #Biostatistics #Dr BustiDisclaimer:This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Hypothesis testing is a core concept in biostatistics and evidence-based medicine. In this This Is Why lecture, Dr. Busti explains how hypotheses guide clinical research design and how clinicians interpret statistical results in medical literature.Understanding hypothesis testing helps clinicians determine whether study findings represent true differences or random chance. In this lecture, we break down null and alternative hypotheses, Type I and Type II errors, alpha and beta, statistical power, and one-tailed versus two-tailed analysis.Using the landmark HOPE Trial, Dr. Busti demonstrates how hypotheses are established a-priori and how proper study design strengthens internal validity and confidence in clinical trial results.This lecture is part of the This Is Why (TIW) Evidence-Based Medicine series with Dr. Busti, where clinicians learn how to interpret and apply clinical research in practice.Topics Covered:- What hypothesis testing means in clinical research- Null hypothesis vs alternative hypothesis- Type I error (alpha) and Type II error (beta)- Statistical power and sample size considerations- One-tailed vs two-tailed hypothesis testing- Why hypotheses must be defined a-priori- Interpreting p-values in clinical trials- Clinical example: the HOPE TrialThis video is part of the This Is Why Evidence-Based Medicine series. Explore the full playlist to continue learning how clinical research works and how to critically evaluate the medical literature.For additional learning resources, explore High-Yield Med Reviews. TIW members can find a member coupon in their TIW benefits section.👉 Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/hypothesis-testing-clinical-research👉 Get more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resources👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.#Biostatistics #HypothesisTesting #EvidenceBasedMedicine #ClinicalResearch #DrBustiDisclaimer:This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Clinical research design and the NIH clinical research process are explained for clinicians. In this This Is Why lecture, Dr. Busti introduces the foundations of clinical epidemiology, biostatistics, and clinical literature evaluation while walking through the NIH framework for how clinical research studies are designed and conducted.Understanding how clinical research is developed—from the original hypothesis to publication—is essential for clinicians who interpret medical literature and apply evidence to patient care. This lecture explains the structure behind clinical trials, research protocols, statistical analysis planning, and the ethical oversight required to conduct high-quality clinical studies.As part of the This Is Why series, this module focuses on the reasoning behind evidence-based medicine so clinicians can move beyond memorizing study results and instead understand how research actually works and how to evaluate the literature correctly.Throughout the TIW series, Dr. Busti connects clinical research design, biostatistics, diagnostic testing, and critical literature evaluation to real clinical decision-making.Topics Covered:- Clinical epidemiology vs biostatistics vs literature evaluation- Foundations of evidence-based medicine- The Five A's of evidence-based medicine- The EBM triad: evidence, clinician expertise, and patient values- NIH clinical research process- Study concept development and hypothesis formation- Protocol development and study design- Ethical oversight and institutional review boards- Study implementation and monitoring- Statistical analysis and interpretation- Communicating research results- Reporting standards, including CONSORT and PRISMA- Foundations for critical appraisal of clinical studiesThis lecture is part of the This Is Why (TIW) evidence-based medicine learning series with Dr. Busti. Each lecture builds on prior concepts to help clinicians develop a deeper understanding of clinical research and medical literature interpretation.👉 Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/nih-clinical-research-design-steps-process👉 Get more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resources👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.#ClinicalResearchDesign #Biostatistics #EvidenceBasedMedicine #ClinicalEpidemiology #Dr BustiDisclaimer:This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

CHA₂DS₂-VASc score atrial fibrillation is a critical concept for determining when anticoagulation is recommended. In this episode of This Is Why with Dr. Busti, we break down a board-style clinical question to explain when anticoagulation should NOT be started in atrial fibrillation.Understanding stroke risk stratification is essential for USMLE, NAPLEX, NP, PA, and medical board exams. This episode walks step-by-step through the reasoning behind anticoagulation decisions using the CHA₂DS₂-VASc scoring system.Topics Covered- CHA₂DS₂-VASc score interpretation- Atrial fibrillation stroke prevention- When anticoagulation is not recommended- AF anticoagulant dosing traps for board exams- Warfarin vs DOAC dosing in AF- Board exam test-taking strategies for AF management The goal = make medical education easy and clinically relevant.👉 Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/cha2ds2-vasc-score-atrial-fibrillation-board-question👉 Get more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resources👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!#afib #atrialfibrillation #cha2ds2vasc #anticoagulation #drbustiDisclaimer:This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

What is proctalgia fugax, and why does this term matter in real clinical practice? In this episode of This Is Why, Dr. Busti breaks down the meaning of proctalgia fugax, its etymology, how it has been understood historically, and how healthcare professionals should use the term today. This lesson focuses on concept-based learning, helping clinicians connect the terminology to differential diagnosis, disorders of gut-brain interaction, and the practical question of whether brief anorectal pain fits proctalgia fugax or points to something else. If you want to understand the “why” behind the words we use in medicine, this episode will help you think more clearly about anorectal pain, diagnosis of exclusion, and patient-centered clinical reasoning.The goal = make medical education easy and clinically relevant.👉 Get more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resources👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!#proctalgiafugax #medicalterminology #anorectalpain #clinicalreasoning #drbustiDisclaimer:This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Short-acting muscarinic antagonists (SAMAs) are a core bronchodilator drug class you’ll see constantly in COPD care. In this lecture from This is Why, Dr. Busti will learn about short-acting muscarinic antagonists (SAMAs) are a core bronchodilator drug class you’ll see constantly in COPD care—and on exams like the NCLEX. In this lecture, you’ll learn exactly how SAMAs work, when to use them, and what safety pearls can help you avoid common clinical pitfalls in COPD.You’ll learn how to:Mechanism of action: muscarinic (M3) blockade → decreased bronchoconstrictionKey drug: ipratropium (Atrovent)Common combinations: ipratropium/albuterol (DuoNeb, Combivent)Clinical uses: COPD maintenance/symptom relief, COPD exacerbation support, select asthma situations (often as add-on therapy in acute care)Routes & devices: MDI vs nebulized treatments, dosing frequency, and practical inhaler/neb pearlsAdverse effects & warnings: dry mouth, cough, urinary retention (BPH), blurry vision/precipitating angle-closure symptoms if sprayed into eyes, and other anticholinergic considerationsHigh-yield comparisons: SAMA vs LAMA (where tiotropium and other long-acting agents fit)The goal = make medical education easy and clinically relevant.Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/sama-short-acting-muscarinic-antagonist-ipratropium-bronchodilatorGet more with a free membership at https://www.thisiswhy.health/Access free downloads from our videos Access deep dive content from Dr. BustiOrganize content via playlists & collectionsJoin live Q&AReceive member newslettersCoupons & discounts for exam prep resourcesIf this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!Disclaimer:This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

In this lecture from This is Why, Dr. Busti will explain the COPD maintenance inhalers you’ll actually see in practice. In this pharmacology review, we break down LAMA (long-acting muscarinic antagonist) bronchodilators—one of the most important bronchodilator classes for COPD treatment—so you can confidently understand the drugs, the mechanism, and the real-world clinical use.You’ll learn how to:What LAMA / antimuscarinic bronchodilators are and how they workWhere LAMA inhalers fit in COPD therapy and long-term symptom controlKey differences and practical pearls for common COPD inhalersHigh-yield side effects, contraindications, and patient counseling pointsHow to recognize and avoid common med errors and confusion with inhaler names/classesDrugs covered:Tiotropium (Spiriva)Umeclidinium (Incruse Ellipta)Aclidinium (Tudorza Pressair)Glycopyrrolate (COPD maintenance formulations)The goal = make medical education easy and clinically relevant.Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/lama-bronchodilators-copd-tiopotropium-umeclidinium-pharmacologyGet more with a free membership at https://www.thisiswhy.health/Access free downloads from our videos Access deep dive content from Dr. BustiOrganize content via playlists & collectionsJoin live Q&AReceive member newslettersCoupons & discounts for exam prep resourcesIf this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!Disclaimer:This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

In this lecture from This is Why, Dr. Busti will break down SABA (Short-Acting Beta Agonist) bronchodilators, like albuterol, for the acute management of asthma symptoms and COPD flare-ups.You’ll learn how to:- What SABAs are and when they’re used (rescue vs controller)- Beta-2 agonist mechanism of action (bronchodilation and smooth muscle effects)- How fast albuterol works, typical duration, and why it’s “short-acting”- Core therapeutic uses in asthma and COPD- How SABAs fit into treatment plans (including “as needed” use)- Common adverse effects: tachycardia, tremor, palpitations, and more- Key patient counseling: inhaler technique and when to seek urgent careDrugs discussed:- Albuterol (rescue inhaler; MDI and nebulizer)- Levalbuterol (alternative SABA)The goal = make medical education easy and clinically relevant.Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/saba-short-acting-beta-agonists-albuterol-rescue-inhaler-asthma-copdGet more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resourcesIf this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!#SABA #albuterol #asthma #COPD #bustiDisclaimer:This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

In this lecture from This is Why, Dr. Busti will explain how Long-Acting Beta Agonists (LABAs) work, where they fit in therapy for the management of asthma and COPD.You’ll learn how to:- Mechanism of action: beta-2 receptor activation → bronchodilation (airway smooth muscle relaxation)- Clinical use: LABAs in COPD maintenance vs asthma (must be combined with ICS)- Onset/duration differences and practical inhaler considerations- Adverse effects & warnings: tachycardia, tremor, hypokalemia, paradoxical bronchospasm, and key safety concepts- Therapeutic combos: ICS/LABA combination inhalers and where they fit (including common guideline concepts)LABA drugs discussed for SEO/review:- Salmeterol- Formoterol- Vilanterol- Olodaterol- IndacaterolThe goal = make medical education easy and clinically relevant.Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/laba-long-acting-beta-agonists-asthma-copd-bronchodilators-pharmacologyGet more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resourcesIf this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!#LABA #LongActingBetaAgonist #Asthma #Bronchodilators #bustiDisclaimer:This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

In this lecture from This is Why, Dr. Busti will break down pioglitazone and the thiazolidinediones (TZDs) so you can confidently explain the mechanism, clinical use, side effects, and key contraindications for type 2 diabetes (T2DM).You’ll learn how to:- TZDs (pioglitazone): where they fit in type 2 diabetes (T2DM) therapy- Mechanism of action: PPAR-γ agonist → increased insulin sensitivity (muscle/adipose) and improved glucose utilization- Expected impact on A1C reduction and how long these drugs take to show benefit- Practical comparisons: pioglitazone vs rosiglitazoneSide effects & safety (high yield)- Weight gain and edema / fluid retention- Heart failure risk (when to avoid TZDs)- Fracture risk with TZDsDrugs covered for SEO / review- Pioglitazone (primary focus)- Thiazolidinediones / TZDs (drug class)- Rosiglitazone (comparison)The goal = make medical education easy and clinically relevant.Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/tzd-thiazolidinediones-pioglitazone-type-2-diabetes-pharmacology-reviewGet more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resourcesIf this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!#pioglitazone #thiazolidinediones #tzd #type2diabetes #bustiDisclaimer:This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Dr. Busti covers one of the most-tested Type 2 diabetes drug classes—sulfonylureas. If you’ve ever mixed up glyburide vs glipizide, worried about hypoglycemia, or wanted a clear “when do I pick this?” framework, this drug class review is for you. In this lecture from This is Why, Dr. Busti will break down Sulfonylureas (Glyburide, Glipizide) step-by-step so you can confidently in the context of treating type 2 diabetes (T2DM).You’ll learn how to:- Mechanism of action: how sulfonylureas increase insulin release- Clinical use: where sulfonylureas still fit in modern Type 2 diabetes management- Drug comparisons: key differences between glyburide, glipizide, and glimepiride- Adverse effects: why hypoglycemia risk matters, plus weight gain and common pitfalls- Safety & patient selection: older adults, renal impairment, missed meals, and other high-risk scenariosKey drugs covered:- Glipizide- Glyburide - Glimepiride- (Plus core concepts of oral hypoglycemics, insulin secretagogues, and antidiabetic drugs)The goal = make medical education easy and clinically relevant.Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/sulfonylureas-glipizide-glyburide-type-2-diabetes-pharmacologyGet more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resourcesIf this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!#sulfonylureas #type2diabetes #glipizide #glyburide #bustiDisclaimer:This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

SGLT2 inhibitors (bexagliflozin, canagliflozin, dapagliflozin, empagliflozin, ertugliflozin) don’t just lower glucose and A1C, but these meds have become relevant in cardiovascular disease and chronic kidney disease in the right patients also with type 2 diabetes (T2DM). In this lecture from This is Why, Dr. Busti will make the SGLT2 inhibitors make sense as they provide cardiorenal protection above their improvements in A1C.You’ll learn how to:- Mechanism of action (MOA): how SGLT2 blockade drives glucosuria, modest A1c reduction, weight loss, and BP lowering- Clinical use: where SGLT2 inhibitors fit for type 2 diabetes, plus major outcomes in heart failure and chronic kidney disease (CKD) (cardiorenal protection is a key reason they’re prioritized in modern guidelines)- Key drugs (for exams + real-world practice): Empagliflozin (Jardiance), Dapagliflozin (Farxiga), Canagliflozin (Invokana), Ertugliflozin (Steglatro), and Bexagliflozin (Brenzavvy)- Adverse effects & safety pearls: genital mycotic infections, volume depletion/hypotension, AKI considerations, and the “don’t-miss” rare events like euglycemic DKA (plus how to recognize it)The goal = make medical education easy and clinically relevant.Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/sglt2-inhibitors-canagliflozin-dapagliflozin-empagliflozin-diabetes-pharmacology-reviewGet more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resourcesIf this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!#sglt2inhibitors #empagliflozin #type2diabetes #diabetespharmacology #bustiDisclaimer:This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Meglitinides (Nateglinide & Repaglinide) can feel like the “forgotten” oral diabetes drugs—but they show up on exams, in real-world medication histories, and in questions about postprandial glucose control and hypoglycemia and weight gain risk. In this lecture from This is Why, Dr. Busti will explain the meglitinides in a clear, clinically relevant way so you can recognize them quickly and use the concepts confidently in the context of Type 2 diabetes (T2DM).You’ll learn how to:- Meglitinides overview: where they fit in type 2 diabetes (T2DM) therapy- Drug names you must know: repaglinide and nateglinide- Mechanism of action: how these insulin secretagogues stimulate insulin release (the KATP channel connection)- Onset/duration & dosing concept: why they’re considered short-acting / prandial glucose agents- Therapeutic application: targeting postprandial hyperglycemia and when they may (or may not) be chosen- Adverse effects & safety: hypoglycemia, weight considerations, and key patient counseling pointsThe goal = make medical education easy and clinically relevant.Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/meglitinides-repaglinide-nateglinide-diabetes-pharmacology-reviewGet more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resourcesIf this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!#meglitinides #repaglinide #nateglinide #type2diabetes #bustiDisclaimer:This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Insulin doesn’t have to be confusing when learning how to treat Type 1 and Type 2 diabetes mellitus. In this lecture from This is Why, Dr. Busti will explain how to quickly recognize insulin types, predict onset/peak/duration, and apply basal–bolus dosing concepts to real-world Type 1 and Type 2 diabetes care.You’ll learn how to:- How to identify rapid-, short-, intermediate-, and long-acting insulin for Diabetes- The difference between basal insulin vs bolus (mealtime) insulin- How basal–bolus regimens work (plus common pitfalls)- Practical tips for insulin administration, timing with meals, and avoiding errors- High-yield clinical points you’re likely to see in courses and on examsInsulins covered (for memorization + exam success):- Rapid-acting: insulin lispro, aspart, glulisine- Short-acting: regular insulin- Intermediate-acting: NPH insulin- Long-acting / basal: insulin glargine, detemir, degludec- Premixed options: 70/30 mixes (NPH/regular and related premixed products)The goal = make medical education easy and clinically relevant.Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/insulin-types-diabetes-pharmacology-reviewGet more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resourcesIf this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!#insulin #diabetes #insulintypes #diabetespharmacology #bustiDisclaimer:This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Understand the GLP-1 receptor agonists—and why agents like semaglutide (Ozempic/Wegovy/Rybelsus), liraglutide, dulaglutide, and exenatide have become one of the most talked-about type 2 diabetes medications in modern practice. In this lecture from This is Why, Dr. Busti will break GLP-1s down in a clear, clinically relevant way so you can confidently explain how they work, when to use them, and what to watch for clinically when managing patients with type 2 diabetes and/or obesity.You’ll learn how to:- Mechanism of action: incretin mimetic effects (GLP-1) and what that means for glucose control- Therapeutic use: where GLP-1 agonists fit in type 2 diabetes (T2DM) treatment strategies- Key agents: semaglutide, plus comparisons to liraglutide, dulaglutide, and exenatide- Benefits & counseling pearls: weight effects, dosing basics, and practical patient education- Adverse effects & precautions: the high-yield safety points clinicians get tested on (and seen in clinical practice)The goal = make medical education easy and clinically relevant.Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/glp-1-receptor-agonists-semaglutide-dulaglutide-liraglutide-diabetes-pharmacology-reviewGet more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resourcesIf this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!#glp1receptoragonist #semaglutide #type2diabetes #diabetesmedications #bustiDisclaimer:This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Tirzepatide (Mounjaro/Zepbound)—the dual incretin GIP/GLP-1 agonist—is a beneficial treatment of type 2 diabetes and/or obesity.  In this lecture from This is Why, Dr. Busti will break down how tirzepatide works (MOA), why combining GIP + GLP-1 improves A1C reduction and supports weight loss, and where it fits in the treatment of type 2 diabetes. You’ll also get the high-yield points you need for exams and the bedside: tirzepatide dosing basics, common adverse effects, contraindications/precautions, and practical tips for patient counseling (nausea, GI effects, injection technique, and expectations).You’ll learn how to:- Tirzepatide overview: Mounjaro vs Zepbound- GIP/GLP-1 agonist mechanism (dual incretin)- Clinical use in type 2 diabetes- A1C lowering + weight loss effects- Adverse effects, warnings, and counseling pearlsThe goal = make medical education easy and clinically relevant.👉 Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/tirzepatide-mounjaro-zepbound-gip-glp1-agonist-type-2-diabetes-pharmacology👉 Get more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resources👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!#tirzepatide #mounjaro #gipglp1 #type2diabetes #bustiDisclaimer:This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

In this lecture from This is Why, Dr. Busti will learn about the application of DPP-4 inhibitors in the management of type 2 diabetes mellitus (T2DM). The DPP-4 inhibitors (e.g., sitagliptin, linagliptin, saxagliptin) have an impact of incretins (GIP, GLP-1) which have continued to evolve in other treatment options.You’ll learn how to:- Mechanism of action: DPP-4 inhibition and impact on incretins (GLP-1/GIP) - Key drugs: Sitagliptin, linagliptin, saxagliptin- Clinical role: where DPP-4 inhibitors fit in type 2 diabetes treatment, including add-on therapy- Adverse effects & safety pearls: the side effects and warnings you need to know for exams and practiceThe goal = make medical education easy and clinically relevant.👉 Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/dpp-4-inhibitors-sitagliptin-type-2-diabetes-pharmacology👉 Get more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resources👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!#dpp4inhibitors #type2diabetes #sitagliptin #diabetespharmacology #bustiDisclaimer:This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.